Previous studies have revealed that its exogenous administration shows an anti-inflammatory effect in a mouse model of mevalonate kinase deficiency and inhibits NF-κB activation in hepatocarcinogenic rat models [19,20]. The gene discussed is MVK; the disease is hyperinsulinemic hypoglycemia, familial, 4.